CURA_1170x120_8-22-19

Philip Hampton

Iain Mackay appointed CFO at GSK

Iain Mackay appointed CFO at GSK

 LONDON — GlaxoSmithKline (GSK) announced that Iain Mackay has been appointed GSK’s next chief financial officer (CFO). He has also been appointed as an Executive Director to the GSK board. Mackay will join the company on January 14, 2019.  Mackay joins GSK from the global bank HSBC, where he has been Group Finance Director for

GlaxoSmithKline tabs consumer health chief as CEO

GlaxoSmithKline tabs consumer health chief as CEO

LONDON — Emma Walmsley has been named to succeed Sir Andrew Witty as chief executive officer of GlaxoSmithKline plc. The drug maker said Tuesday that Walmsley, CEO of GSK Consumer Healthcare, is slated to take the reins from Witty when he retires on March 31, 2017. Plans call for her to become a member of

GlaxoSmithKline CEO Andrew Witty to retire

GlaxoSmithKline CEO Andrew Witty to retire

LONDON — Sir Andrew Witty, chief executive officer of GlaxoSmithKline plc, plans to retire from the company next year. GSK announced Witty’s retirement Thursday in releasing its 2015 annual report to shareholders. Plans call for Witty to step down from the CEO post on March 31, 2017. The board of directors plans to conduct a